Synvista Therapeutics, Inc.
SYNI
$0.00
$0.000.00%
| 09/30/2008 | 06/30/2008 | 03/31/2008 | 12/31/2007 | 09/30/2007 | |
|---|---|---|---|---|---|
| Revenue | -6.54% | -5.35% | 68.12% | 64.57% | 13.20% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -6.54% | -5.35% | 68.12% | 64.57% | 13.20% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -6.54% | -5.35% | 68.12% | 64.57% | 13.20% |
| SG&A Expenses | -10.88% | -14.91% | -22.41% | -15.75% | 38.59% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.80% | 45.93% | 65.73% | 52.09% | 47.37% |
| Operating Income | -18.10% | -46.68% | -65.71% | -51.97% | -47.92% |
| Income Before Tax | 24.22% | 48.48% | 24.43% | 8.97% | 22.66% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 24.22% | 48.48% | 24.43% | 8.97% | 21.28% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 24.22% | 48.48% | 24.43% | 8.97% | 21.28% |
| EBIT | -18.10% | -46.68% | -65.71% | -51.97% | -47.92% |
| EBITDA | -21.59% | -52.20% | -73.40% | -48.96% | -44.75% |
| EPS Basic | -23.12% | 22.94% | 18.49% | 29.49% | 52.14% |
| Normalized Basic EPS | 32.67% | 7.53% | -55.89% | -69.20% | -33.75% |
| EPS Diluted | -23.12% | 22.94% | 18.49% | 29.49% | 52.14% |
| Normalized Diluted EPS | 32.67% | 7.53% | -55.89% | -69.20% | -33.75% |
| Average Basic Shares Outstanding | -0.08% | 3.66% | 18.51% | 41.66% | 76.43% |
| Average Diluted Shares Outstanding | -0.08% | 3.66% | 18.51% | 41.66% | 76.43% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
